Director Quality
Abbott
Pat Weixel joined Abbott Laboratories in January of 2024, in the corporate office as a Director of Regulatory Affairs for the Premarket Review Team in Global Strategic Regulatory. Pat is currently a Director of Quality within Abbott’s Business Support team. Prior to joining Abbott, Pat worked at FDA for 31 years. He began his FDA career as an FDA Investigator focusing on Device inspections and then went to the Center for Devices and Radiological Health (CDRH). At CDRH, Pat focused on the evaluation of regulatory actions such as warning letters, seizures and injunctions. He was very active in the development of Sterilization and Packaging standards for over 20 years and enjoyed training CDRH and FDA Investigators on the Quality System regulation and review of regulatory actions.
Breakout #1: QMSR - Are You Ready?
Thursday, April 24, 2025
12:30 PM – 2:00 PM East Coast USA Time